Mumbai :  Abbott has been named the ‘Multinational Pharmaceutical Company of the Year’ for the third consecutive year at the 2013 Frost & Sullivan India Healthcare Excellence Awards held in Mumbai on Friday.

The prestigious annual award from Frost and Sullivan acknowledges best practices in the healthcare industry and measures companies on parameters such as revenue and market share growth, geographical and product line expansion, visibility of the company, value-added services, strategic and technological innovation, and clinical excellence. Abbott was recognised for its outstanding performance against these criteria in2012-2013.

With a heritage of over 100 years in India, Abbott is committed to investing in building its local capabilities —through people, infrastructure, innovation and partnerships — while benefiting from being a part of one of the world’s leading healthcare companies.

Congratulating Abbott on the award, Sandeep Sinha, Director, Healthcare and Life Sciences Practice, Frost & Sullivan, said, “Our analysis shows that Abbott India’s success is a combination of a diversified product portfolio, focused execution, and attention to fulfilling the unmet health needs of patients. Abbott’s performance and growth represents continuous efforts in terms of innovation, accessibility, and affordability of medicine to patients at large in India.”

Commenting on the award, Rehan A. Khan, Managing Director, Abbott India Ltd, said, “As one of India’s oldest healthcare companies, we take pride in applying our knowledge and expertise to help address the country’s most relevant healthcare challenges and needs. Abbottis honoured to be recognised for our commitment to improving access tohigh-quality and affordable, branded generic medicines that have been successfully treating patients for many years.”

Abbott is one of the leading healthcare companies in India, providing consumers with a diverse range of established pharmaceuticals, nutritional products, medical devices, and diagnostic tests. Also ranked the number one company in the Indian pharmaceutical market1.,Abbotthas 20 pharmaceutical brands in the Top 300 in the country and has substantial expertise and a strong presence in important therapy areas like cardio-metabolic, gastroenterology, women’s health, neurosciences, cough management, antibiotics, pain and dermatology.

Source : Lokesh Shastri